The New Multi-Billion Dollar Drug on the Block? Daniel Carcillo, Robert O’Leary and Dr. Sharmin Ghaznavi Talk Psilocybin
Two-time Stanley Cup Champion Daniel Carcillo shares his post-sports career struggles and advocacy to treat traumatic brain injury and depression with an unconventional psychedelic: Psilocybin. He is joined by Kevin O’Leary to analyze the future of the drug and by Dr. Sharmin Ghaznavi on the science and technology.
May 31, 202121m 10s
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Two-time Stanley Cup Champion Daniel Carcillo shares his post-sports career struggles and advocacy to treat traumatic brain injury and depression with an unconventional psychedelic: Psilocybin. He is joined by Kevin O’Leary to analyze the future of the drug and by Dr. Sharmin Ghaznavi on the science and technology. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.
Topics
psychedelicsshark tankmicrodosingmagic mushroomstraumatic brain injurypsychedelics treatmentkevin o’learypsilocybin therapy